Allergan Can't Escape Generic Drug Price-Fixing Suit
Allergan must face a proposed class action accusing the pharmaceutical company of taking part in a generic drug price-fixing scheme after a New Jersey federal judge rejected the company's dismissal bid...To view the full article, register now.
Already a subscriber? Click here to view full article